Sustained Growth at Eden Biodesign Results in the Posting of 18 New Job Openings

Sustained Growth at Eden Biodesign Results in the Posting of 18 New Job Openings

The Company's Global Reach, Continued Strong Growth, and Significant New Contracts has Fueled Demand for an Expanded Workforce

LIVERPOOL, United Kingdom & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Eden Biodesign, a globally-integrated provider of biopharmaceutical process development, cGMP manufacturing, and consultancy services, today announced that it has posted eighteen (18) new job openings located at its Liverpool, UK state-of-the-art licensed cGMP facility.

Given the breath and depth of Eden Biodesign's contract manufacturing and consultancy services - which have achieved global recognition in the biopharmaceutical marketplace - and the continued strong growth in Eden Biodesign's project portfolio, the positions to be filled demand a wide range of skills in manufacturing, development and quality teams. The full list of the open positions can be viewed at: http://linux.edenbiodesign.com/join-us.html.

The creation of these positions at Eden Biodesign comes after a string of positive developments at the Company, including Eden Biodesign's selection by Biotecnol SA to manufacture Cardiotrophin-1 for potential use in certain liver indications and Omnio Healer AB, for cGMP Production of Clinical Trial Product in Wound Healing and Anti-infection. Eden Biodesign has also entered into a range of collaborative partnerships with technology leaders such as Selexis SA and Millipore for high productivity cell line development.

"We can attribute our success to a staff of extraordinary and talented professionals at Eden Biodesign," said Crawford Brown, PhD, chief executive officer for Eden Biodesign. "Now, we are expanding that team by drawing world-class talent of the highest caliber to support our rapidly expanding global client base."

About Eden Biodesign

Eden Biodesign is a globally-integrated biopharmaceutical company offering consultancy, biopharmaceutical design and cGMP manufacturing services to leading biotech and pharmaceutical clients around the world. With a reputation for successfully commercializing biopharmaceutical products and processes, the Company offers expertise and guidance in multiple sectors. Eden's world-class facilities and knowledge in process development, manufacturing, regulatory and technology transfer support ensures Eden Biodesign offers much more than a traditional CMO. Learn more at www.edenbiodesign.com.

Suggested Articles

Last month, rumors out of Bloomberg whispered that Gilead, more known for its COVID-19 work these days, was gearing up for a major stake in Arcus.

The NGOs think Big Pharma controls the agenda of the IMI, leading it to prioritize areas that are profitable for drugmakers over public health needs.

Scientists at McMaster University and the University of Toronto have formed Empirica Therapeutics to bring a CAR-T for glioblastoma into the clinic.